Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Insights/Evidence synthesis/What is a meta-analysis in Cochrane reviews?

What is a meta-analysis in Cochrane reviews?

Pooling results into a single estimate — and the harder editorial judgement is whether the studies should be combined at all.

Synthesis and analysis

What it does

A meta-analysis combines effect estimates from individual studies into a weighted summary, with studies weighted by precision. The result is a pooled estimate with a confidence interval, usually displayed as a forest plot.

In a Cochrane review, meta-analysis sits inside the review; it is not the review. Many Cochrane reviews deliberately present no pooled estimate because pooling would not be appropriate.

Fixed-effect and random-effects

A fixed-effect model assumes one true effect, with differences between studies due to sampling error alone. A random-effects model assumes the true effect varies between studies and estimates the average of that distribution.

Random-effects gives relatively more weight to small studies, which matters when small studies are systematically different — so it is not simply the safer default. The choice should follow from whether a single common effect is plausible, and should be stated in the protocol.

Heterogeneity

I² describes the proportion of variability attributable to heterogeneity rather than chance. It is widely over-interpreted: it is not an absolute measure of how much the effects differ, and it increases with the precision of the included studies, so large trials can produce a high I² for clinically trivial differences.

Tau-squared and the prediction interval are more informative about the actual spread of effects. A prediction interval that crosses no effect, where the confidence interval does not, is an important finding and is often omitted.

Clinical and methodological heterogeneity matter before statistical heterogeneity. If the populations, interventions or outcomes differ in ways that make a common effect implausible, the studies should not be pooled no matter what I² says.

What goes alongside the estimate

A forest plot showing each study. A risk of bias assessment feeding sensitivity analysis. Investigation of heterogeneity through pre-specified subgroup analysis or meta-regression — both of which are observational across studies and cannot support causal claims about the subgroup. A GRADE certainty rating and a summary of findings table.

In practice

Fix, flag or query.

The distinction that keeps an edit defensible: what an editor may change silently, what must be shown to the author, and what only the author can answer.

  • Decide clinical comparability before looking at I².
  • Report the prediction interval, not only the confidence interval.
  • Treat subgroup findings as hypothesis-generating, always.

Sources

  • Cochrane Handbook, chapters on meta-analysis and heterogeneity
  • GRADE Working Group, summary of findings tables

Sources are given so each claim can be checked at its origin. Where a tool’s current maintenance status could not be confirmed, the page says to check it rather than asserting it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.